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Abstract
Background: The pancreas is a rare but occasionally favored target for metastasis. Metastatic
lesions in the pancreas have been described for various primary cancers, such as carcinomas of the
lung, the breast, renal cell carcinoma and sarcomas.
Case presentation: We report the case of a 60-year old female with a mass in the pancreatic
head four years after partial gastrectomy for gastric adenocarcinoma. The patient underwent a
pancreatoduodenectomy. Pathological examination revealed metastases of the primary gastric
carcinoma within the pancreatic head and in regional lymph nodes.
Conclusions: Pancreatic tumors in patients with a history of non-pancreatic malignancy should
always be considered to be a putative metastatic lesion at an unusual site. If the pancreas can be
identified as the only site of spread, radical resection may prolong survival.
Background
The pancreas is an uncommon location for solitary metas-
tasis from other primary cancers [1]. Despite this, in large
autopsy series the prevalence of pancreatic metastasis has
been described to be as high as 6% to 11% [2]. Whereas
renal cell carcinoma appears to be the most common pri-
mary tumor to cause secondary pancreatic tumors, a vari-
ety of other cancers may spread to the pancreas, such as
colon cancer, non-small cell lung cancer, and sarcomas
[3]. This article presents the case of a pancreatic metastasis
presenting as first site of gastric cancer recurrence four
years after primary diagnosis.
Case presentation
A 60-year-old woman presented with elevated blood lev-
els of the tumor markers CEA (17.3 µg/L, normal <2.5 µg/
L) and CA 19-9 (121 U/ml, normal <37 U/ml). Four years
before being referred to our institution, the patient had
undergone gastric resection (Billroth II gastrectomy) for
an adenocarcinoma of the stomach. The tumor was
located at the lesser curvature of the gastric antrum, meas-
uring 3 cm in the largest diameter. Pathologic examina-
tion revealed a gastric carcinoma of low differentiation,
which infiltrated the gastric wall into the subserosal layer
without penetrating the serosa. Microscopically, the carci-
noma was mainly composed of tubular formations of
mitotically active, atypical epithelial cells (Figure 1A). The
tumor also displayed areas of marked desmoplastic
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stromal reaction, as well as areas of rather glandular differ-
entiation. The latter two were mainly observed in paragas-
tric lymph node metastases (Figure 1B). The carcinoma at
stage pT2 pN1 (6/15) M0 G2 was completely resected (R0
resection). No recurrence was detected during the regular
follow-ups.
Four years after gastric resection, however, ultrasound
examination, computed tomography and magnetic reso-
nance imaging revealed an inhomogeneous mass of the
pancreatic head, measuring 4 cm in largest diameter (Fig-
ure 2). Radiographically, no other masses were detected.
For differential diagnosis, a primary carcinoma of the pan-
creas and a metastasis of the gastric carcinoma were con-
sidered. Following explorative laparotomy, the pancreatic
mass was resected performing a partial pancreatoduo-
denectomy with resection of the distal bile duct (Whip-
ple's procedure). Furthermore, the former
gastroenterostomy was resected and revised. On patho-
logic examination, the tumor of the pancreatic head
grossly presented as white to yellowish, firm mass. Micro-
scopically, the tumor consisted of solid and glandular for-
mations of atypical epithelial cells with distinct nuclear
pleomorphism and presented marked desmoplastic stro-
mal reaction, as well as areas of necrosis (Figure 3). The
duodenal wall and the peripancreatic tissue were
infiltrated by the tumor. Lymph node metastases were
detected in two peripancreatic lymph nodes. The histo-
morphological appearance of the pancreatic tumor was in
good accordance to some areas of the primary gastric
tumor, and especially the growth pattern found in the par-
agastric lymph node metastases coped well with the
microscopic picture found in the pancreatic tumor.
Immunohistochemical analyses revealed identical expres-
sion patterns in the gastric carcinoma and the pancreatic
mass, both displaying positive reactions with antibodies
towards cytokeratins 8, 18 and 19, as well as carcinoem-
bryonic antigen (CEA), whereas no reactions were seen
with antibodies towards cytokeratins 7 and 20. Because of
these findings and due to the lack of pancreatic cancer
progenitor lesions, pancreatic intraepithelial neoplasias
(PanINs), within the non-neoplastic pancreatic tissue of
the Whipple's resection specimen, the pancreatic tumor
and the two regional lymph node metastases were consid-
ered to be metastases of the primary gastric carcinoma.
The patient was discharged from the hospital without any
perioperative morbidity on the ninth postoperative day.
The postoperative blood levels of the tumor markers
declined to normal values (CEA 2.6 µg/l, CA 19-9 24 U/
ml). Due to the complete surgical resection and the lack of
risk factors for recurrence, the patient received no further
adjuvant therapy. Under regular follow-up for one year
with determination of the tumor markers and computed
tomography, the patient revealed no signs or symptoms of
local or systemic recurrence.
Discussion
Death from recurrence of gastric adenocarcinoma occurs
in 70–75% of patients during the first two years after sur-
gical intervention, however, reports of recurrences more
than 10 years after primary diagnosis have been reported
Histomorphologic appearance of the primary gastric carci- noma (A) and a paragastric lymph node metastasis (B) Figure 1
Histomorphologic appearance of the primary gastric carci-
noma (A) and a paragastric lymph node metastasis (B). Phot-
omicrograph shows that the primary tumor is mainly 
composed of solid and tubular formations, whereas, a 
marked desmoplastic stromal reaction is seen in the lymph 
node metastasis. (hematoxylin and eosin × 40).
Computed tomography of the abdomen four years after Bill- roth II resection for gastric cancer, revealing an inhomoge- nous mass in the pancreatic head, 4 cm in diameter Figure 2
Computed tomography of the abdomen four years after Bill-
roth II resection for gastric cancer, revealing an inhomoge-
nous mass in the pancreatic head, 4 cm in diameter. (Picture 
courtesy the Division of Radiology, German Cancer 
Research Center, provided by PD Dr. med. S. Delorme).World Journal of Surgical Oncology 2004, 2:43 http://www.wjso.com/content/2/1/43
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as well [4]. The most frequent sites of tumor recurrences
include local, regional and peripheral lymph nodes, as
well as the liver, the lungs, and the peritoneum [5]. Fur-
thermore, solitary metastasis in other organs, such as the
thyroid gland or the spleen have been described [6,7]. In
contrast to direct infiltration into the pancreas, metastases
of gastric cancer into the pancreas are considered to be
extremely rare and to our knowledge only four cases have
been reported in the English literature [8-10].
Adenocarcinomas of the pancreas and of other primary
sites frequently display a large histomorphological and
immunohistochemical overlap. Thus the differential diag-
nosis of primary pancreatic cancer versus solitary metas-
tases of other adenocarcinomas may be very difficult – if
not impossible – using common pathological and immu-
nohistochemical techniques. According to Robbins et al
[3], solitary pancreatic masses can be classified as second-
ary tumors to the pancreas in only 2% of the cases, and
they are frequently misdiagnosed as primary pancreatic
cancers. As a consequence from this, the subtle diagnostic
work-up for isolated masses in the pancreas needs to
inherit a meticulous elaboration of the medical history of
the patients, in particular focused on previous non-pan-
creatic malignancy.
Pancreatic resections can nowadays be performed with
low morbidity and mortality rates, in particular in high-
volume centers [11,12]. Results of surgical extirpation of
isolated metastases to the pancreas from various primary
tumors provide improvement with regard to long-term
survival [1,2]. Therefore, a resection of isolated metastases
in the pancreas should be considered as a treatment
option in patients with the history of non-pancreatic
malignancy [13].
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